Oral Decitabine/Cedazuridine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Oral Decitabine/Cedazuridine, covering 2024-10-02 to 2025-03-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia [Phase 3]